Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Candotti

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The EMBO Journal|March 17, 1999
Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domainN A Cacalano, T S Migone, F Bazan, et al.
Scandinavian Journal of Immunology|June 16, 2011
Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotypeM Moncada-Vélez, A Vélez-Ortega, J Orrego, et al.
The Journal of Biological Chemistry|March 14, 1997
Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiencyN Taylor, F Candotti, S Smith, et al.
Nature|September 7, 1995
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)P Macchi, A Villa, S Giliani, et al.
Human Genetics|September 12, 2000
Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphismR F Schumacher, P Mella, R Badolato, et al.
British Journal of Haematology|September 30, 1998
Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatmentF Bozzi, G Lefranc, A Villa, et al.
Molecular and Cellular Biology|May 29, 2000
Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activationY J Zhou, K S Magnuson, T P Cheng, et al.
Immunobiology|September 19, 2000
Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a modelL D Notarangelo, S Giliani, P Mella, et al.
Prenatal Diagnosis|March 12, 1999
Prenatal molecular diagnosis of Wiskott-Aldrich syndrome by direct mutation analysisS Giliani, M Fiorini, P Mella, et al.
Clinical Immunology (Orlando, Fla.)|May 4, 2000
Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterizationP Mella, L Imberti, D Brugnoni, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The EMBO Journal|March 17, 1999
Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domainN A Cacalano, T S Migone, F Bazan, et al.
Scandinavian Journal of Immunology|June 16, 2011
Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotypeM Moncada-Vélez, A Vélez-Ortega, J Orrego, et al.
The Journal of Biological Chemistry|March 14, 1997
Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiencyN Taylor, F Candotti, S Smith, et al.
Nature|September 7, 1995
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)P Macchi, A Villa, S Giliani, et al.
Human Genetics|September 12, 2000
Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphismR F Schumacher, P Mella, R Badolato, et al.
British Journal of Haematology|September 30, 1998
Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatmentF Bozzi, G Lefranc, A Villa, et al.
Molecular and Cellular Biology|May 29, 2000
Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activationY J Zhou, K S Magnuson, T P Cheng, et al.
Immunobiology|September 19, 2000
Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a modelL D Notarangelo, S Giliani, P Mella, et al.
Prenatal Diagnosis|March 12, 1999
Prenatal molecular diagnosis of Wiskott-Aldrich syndrome by direct mutation analysisS Giliani, M Fiorini, P Mella, et al.
Clinical Immunology (Orlando, Fla.)|May 4, 2000
Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterizationP Mella, L Imberti, D Brugnoni, et al.
Pageof 5